← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vasgene Therapeutics, Inc
Los Angeles, CA
$1,663,132
Total funding
3
Grants
Funding over time
peak $811.3K · FY2012–14$1M$750K$500K$250K$0
'12
'13
'14
Funding mix
By agency
NIH$1,663,132 · 3
By mechanism
R44$1,401,047 · 1
R43$262,085 · 2
Investigators at Vasgene Therapeutics, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of sEphB4-HSA as Novel Therapeutic in Cancer$811,279
R44 · FY2013 · CA
Development of sEphB4-HSA as Novel Therapeutic in Cancer$589,768
R44 · FY2014 · CA
sEphB4-HSA A Pre-Clinical Candidate for Oncology$149,607
R43 · FY2012 · CA
EphB4 Receptor Tyrosine Kinase RTK Targeted Humanized Monoclonal Antibody h131$112,478
R43 · FY2012 · CA